Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,821
Total Claims
$1.4M
Drug Cost
526
Beneficiaries
$2,706
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-91%
Opioid rate vs peers
0.2% vs 2.6% avg
+153%
Cost per patient vs peers
$2,706 vs $1,068 avg
+186%
Brand preference vs peers
25.7% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
44
Opioid Claims
$1,120
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,089 claims · $977K
Generic: 14,717 claims · $445K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,061 | $220K |
| Paliperidone Palmitate | 25 | $77K |
| Dulaglutide | 91 | $56K |
| Rivaroxaban | 264 | $45K |
| Lipase/Protease/Amylase | 32 | $34K |
| Empagliflozin | 130 | $28K |
| Fluticasone/Umeclidin/Vilanter | 56 | $28K |
| Risperidone Microspheres | 20 | $25K |
| Linaclotide | 45 | $24K |
| Sacubitril/Valsartan | 91 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 146 | $22K |
| Insulin Aspart | 84 | $22K |
| Dapagliflozin Propanediol | 100 | $21K |
| Dextromethorphan Hbr/Quinidine | 34 | $20K |
| Meropenem | 50 | $17K |
Prescribing Profile
Patient Profile
76
Avg Age
62%
Female
2.74
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About